ARCHIVES

FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years

This article is from The Cancer Letter archive.

Vol. 11 No. 27 | July 5, 1985

Download PDF Visit The Full Archive

Related Articles

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

AACI Says Fund Reductions Hurt Cancer Centers

March 24, 1978